ApprovalTrail

Approval · Notice of Compliance 17264 · 2015

STANNOUS AGENT: Notice of Compliance 17264

Issued September 10, 2015

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
17264
Date
September 10, 2015
Company
MediamNarcq-En-Baroeul, Nord, France
Product type
Radiopharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New drug product manufacturing site

Products in this notice

BrandDINStatus today
STANNOUS AGENTNot yet assigned—

Medicinal ingredients